Index Venture Life Associates Vi LTD Centessa Pharmaceuticals PLC Transaction History
Index Venture Life Associates Vi LTD
- $242 Million
- Q3 2025
A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $275 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
9,961,789
Previous 9,961,789
-0.0%
Holding current value
$275 Million
Previous $131 Million
84.55%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
140Shares Held
125MCall Options Held
1.49MPut Options Held
787K-
Medicxi Ventures Management (Jersey) LTD20MShares$551 Million73.31% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.8MShares$298 Million3.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10MShares$277 Million0.41% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$267 Million8.3% of portfolio
-
Janus Henderson Group PLC London, X05.41MShares$149 Million0.06% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...